Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...
The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...
GlobalData on MSN1d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSKAbrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for babies found it to be almost 90% effective in reducing hospitalization ...
South Australian families will now have better protection against a potentially deadly respiratory virus, under a free state ...
Pfizer Inc. has announced that the European Commission (EC) has issued a decision amending the marketing authorization for ...
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback